Please login to the form below

Not currently logged in
Email:
Password:

Syros appoints Moderna CEO to board

Stéphane Bancel also has experience at bioMérieux and Lilly
Syros Stephane Bancel

The founding CEO of Moderna Therapeutics, Stéphane Bancel, has joined the board of Syros Pharmaceuticals.

Syros, which focuses on controlling a person's genes to treat cancer and other diseases, will benefit from Bancel's work in RNA therapeutics at Moderna.

The company's CEO Nancy Simonian said: “Stéphane has established an exceptional track record of accomplishment in our industry. His successes in financing and building companies as well as in creating value are widely admired.”

Bancel joined Moderna in 2011, the year after its formation. Notable achievements as CEO include securing a licensing partnership with AstraZeneca potentially worth more than $400m.

Prior to serving as Moderna's CEO, Bancel spent four years as CEO of bioMérieux.

He also spent six years at Lilly, including a spell as country manager for Belgium.

Commenting on his appointment to the board of Syros, he said: “Syros' leadership in understanding gene control opens entirely new avenues to treat cancer and other serious diseases.

“The company's revolutionary approach creates significant opportunity to impact health and create value.”

27th November 2013

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics